BPG is committed to discovery and dissemination of knowledge
Featured Articles
2/20/2025 11:57:09 AM | Browse: 95 | Download: 198
Publication Name World Journal of Hepatology
Manuscript ID 102328
Country China
Received
2024-10-15 02:33
Peer-Review Started
2024-10-15 02:33
To Make the First Decision
Return for Revision
2024-12-24 09:26
Revised
2025-01-04 12:12
Second Decision
2025-01-17 06:07
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-01-18 09:36
Articles in Press
2025-01-18 09:36
Publication Fee Transferred
2025-01-07 02:54
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-02-11 00:48
Publish the Manuscript Online
2025-02-20 08:39
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Role of triggering receptor expressed on myeloid cells 2 in the pathogenesis of non-alcoholic fatty liver disease
Manuscript Source Unsolicited Manuscript
All Author List Li-Hui Zhang, Su-Tong Liu, Qing Zhao, Xiao-Yan Liu, Tong Liu, Qiang Zhang, Minghao Liu and Wen-Xia Zhao
Funding Agency and Grant Number
Funding Agency Grant Number
Henan Province's "Double First-Class" Creation of Scientific Research in Traditional Chinese Medicine No. HSRP-DFCTCM-2023-7-23
Henan Province's "Double First-Class" Creation of Scientific Research in Traditional Chinese Medicine No. STG-ZYX02-202117
National Traditional Chinese Medicine Clinical Research Base Scientific Research Special Project No. 2022JDZX098
National Traditional Chinese Medicine Clinical Research Base Scientific Research Special Project No. 2022JDZX114
National Natural Science Foundation of China No. 82205086
The 9th China Association for Science and Technology Young Talent Support Project No. 2023QNRC001
Corresponding Author Wen-Xia Zhao, Chief Physician, MD, Professor, Collaborative Innovation Center of Prevention and Treatment of Major Diseases by Chinese and Western Medicine, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, Henan Province, China. zhao-wenxia@163.com
Key Words Triggering receptor expressed on myeloid cells 2; Non-alcoholic fatty liver disease; Macrophage; Lipid metabolism; Inflammation
Core Tip Triggering receptor expressed on myeloid cells 2 (TREM2) is an immunoglobulin superfamily receptor located on the cell membrane. In the liver, it is mainly expressed on macrophages. TREM2 plays an important regulatory role in lipid metabolism, inflammation, fibrosis, and hepatocellular carcinoma, and is considered a potential therapeutic target for non-alcoholic fatty liver disease (NAFLD) (for example, macrophages with high expression of TREM2 can effectively clear apoptotic liver cells in a timely manner), thereby inhibiting chronic liver inflammation and non-alcoholic steatohepatitis lesions caused by obesity. This article highlights the most recent research developments on TREM2 in NAFLD, in an attempt to identify new pathways for NAFLD treatment.
Publish Date 2025-02-20 08:39
Citation <p>Zhang LH, Liu ST, Zhao Q, Liu XY, Liu T, Zhang Q, Liu M, Zhao WX. Role of triggering receptor expressed on myeloid cells 2 in the pathogenesis of non-alcoholic fatty liver disease. <i>World J Hepatol</i> 2025; 17(2): 102328</p>
URL https://www.wjgnet.com/1948-5182/full/v17/i2/102328.htm
DOI https://dx.doi.org/10.4254/wjh.v17.i2.102328
Full Article (PDF) WJH-17-102328-with-cover.pdf
Manuscript File 102328_Auto_Edited_013725.docx
Answering Reviewers 102328-answering-reviewers.pdf
Audio Core Tip 102328-audio.m4a
Conflict-of-Interest Disclosure Form 102328-conflict-of-interest-statement.pdf
Copyright License Agreement 102328-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 102328-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate 102328-non-native-speakers.pdf
Peer-review Report 102328-peer-reviews.pdf
Scientific Misconduct Check 102328-scientific-misconduct-check.png
Scientific Editor Work List 102328-scientific-editor-work-list.pdf
CrossCheck Report 102328-crosscheck-report.pdf